Syndax Pharmaceuticals, Inc.SNDXNASDAQ
Loading
Debt to Assets Over TimeElevated
Percentile Rank79
3Y CAGR+554.3%
5Y CAGR+57.1%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+554.3%/yr
Annual compound
5Y CAGR
+57.1%/yr
Recent acceleration
Percentile
P79
Within normal range
vs 5Y Ago
9.6x
Strong expansion
Streak
3 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.65 | +37.1% |
| 2024 | 0.48 | +17780.4% |
| 2023 | 0.00 | +14.3% |
| 2022 | 0.00 | -95.0% |
| 2021 | 0.05 | -31.7% |
| 2020 | 0.07 | +383.8% |
| 2019 | 0.01 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |